Schedule of Quarterly Financial Information [Table Text Block] |
The information below has been prepared on a basis consistent with our audited consolidated financial statements. | | 2015 Quarters (unaudited) | | (in thousands, except per share data) | | First | | Second | | Third | | Fourth | | Net revenues | | $ | 18,799 | | $ | 19,516 | | $ | 19,972 | | $ | 18,035 | | Total operating expenses | | | 9,232 | | | 11,102 | | | 11,521 | | | 11,767 | | Operating income from continuing operations | | | 9,567 | | | 8,414 | | | 8,451 | | | 6,268 | | Net income from continuing operations | | $ | 4,369 | | $ | 3,571 | | $ | 4,559 | | $ | 2,876 | | Basic and diluted income from continuing operations per share: | | | | | | | | | | | | | | Basic income per share from continuing operations | | $ | 0.38 | | $ | 0.31 | | $ | 0.40 | | $ | 0.25 | | Diluted incomeper share from continuing operations | | $ | 0.38 | | $ | 0.31 | | $ | 0.39 | | $ | 0.25 | | | | 2014 Quarters (unaudited) | | (in thousands, except per share data) | | First | | Second | | Third | | Fourth(1) | | Net revenues | | $ | 10,899 | | $ | 6,647 | | $ | 17,387 | | $ | 21,037 | | Total operating expenses | | | 7,404 | | | 9,107 | | | 9,188 | | | 10,265 | | Operating income/(loss) from continuing operations | | | 3,495 | | | (2,460) | | | 8,199 | | | 10,772 | | Net income/(loss) from continuing operations | | $ | 3,359 | | $ | (2,363) | | $ | 6,746 | | $ | 21,005 | | Basic and diluted income/(loss) from continuing operations per share: | | | | | | | | | | | | | | Basic income/(loss) per share from continuing operations | | $ | 0.33 | | $ | (0.21) | | $ | 0.59 | | $ | 1.85 | | Diluted income/(loss) per share from continuing operations | | $ | 0.33 | | $ | (0.21) | | $ | 0.59 | | $ | 1.82 | | ____________________________________________________________ (1) Net income from continuing operations, Basic income per share from continuing operations, and Diluted income per share from continuing operations for the fourth quarter of 2014 include the impact of an income tax benefit to reverse $16.7 million of the valuation allowance preiously recorded against our deferred tax assets.
|